Olympus announces the release of the EndoEYE Flexible Video Cystoscope(shown), which features a high-resolution simultaneous-multi-color cameraat the distal tip, producing a high-quality video image.
NPX887 being explored in HHLA2+ solid tumors, including RCC
The study plans to enroll 144 patients with solid tumors, including RCC, non-small cell lung cancer, colorectal carcinoma (CRC), and other malignancies known to express HHLA2/B7-H7.
Dr. Murphy on increasing diversity in cancer clinical trials
In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
Money Matters: Removing excess Roth IRA contributions
"An excess contribution into a Roth IRA can be a hassle, but it is correctible," writes Jeff Witz, CFP.
Dr. Schwen on focal therapies for prostate cancer
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
Study launches of cretostimogene grenadenorepvec in NMIBC
"Cretostimogene is a novel therapy which has the potential to be a paradigm shift in how we might manage the ongoing burden of this highly recurrent aspect of bladder cancer,” says Neal D. Shore, MD, FACS.
Decipher prostate test receives high evidence rating in NCCN guidelines
The Decipher test is a 22-gene prognostic tool used for the risk stratification of patients with localized prostate cancer.
2 Commerce Drive Cranbury, NJ 08512